MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway

AbstractMyeloid differentiation primary response gene 88 (MyD88), an adaptor protein in the Toll-like receptors (TLRs) signalling pathway, is expressed in various liver cells including hepatocytes, Kupffer cells and hepatic stellate cells (HSCs). And yet, the functional role of MyD88 in HSCs is poorly elucidated in alcoholic fatty liver (AFL). Here, to study the functional role of MyD88 in HSCs and the molecular mechanism related to the development of AFL, chronic-binge ethanol mouse models were established in mice with specific MyD88 knockout in quiescent (MyD88GFAP −KO) and activated HSCs (MyD88SMA −KO), respectively. Our results clearly showed an elevated expression of MyD88 in liver tissues of ethanol treated mouse model which harbours the wild type. Intriguingly, ethanol treatment profoundly inhibited inflammation in both MyD88GFAP −KO and MyD88SMA −KO mice, but the suppression of lipogenesis was only observed in MyD88GFAP −KO mice. Molecularly, our study indicated that MyD88 induced osteopontin (OPN) secretion in HSCs, which consequently resulted in activation of AKT signalling pathway and accumulation of fat in hepatocytes. Additionally, our data also suggested that OPN promoted inflammation by activating p-STAT1. Thus, targeting MyD88 may be a potentially represent a promising strategy for the prevention and treatment of AFL.Key messagesThe expression of MyD88 in HSCs was significantly increased in ethanol-induced liver tissues of wild-type mice.MyD88 defici...
Source: Journal of Molecular Medicine - Category: Molecular Biology Source Type: research